{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:38:04Z","timestamp":1771511884810,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00417-024-06716-2","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T09:57:22Z","timestamp":1735898242000},"page":"1417-1426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Elimination of oral foci of infection might lead to clinical improvement of Graves\u2019 orbitopathy"],"prefix":"10.1007","volume":"263","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1510-4702","authenticated-orcid":false,"given":"Nadia","family":"Sawicka-Gutaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicja","family":"Sta\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Sta\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawid","family":"Gruszczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Zawalna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateusz","family":"Pochylski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Rucha\u0142a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"key":"6716_CR1","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/s0140-6736(16)00278-6","volume":"388","author":"SD Leo","year":"2016","unstructured":"Leo SD, Lee SY, Braverman LE (2016) Hyperthyroidism. Lancet 388:906\u2013918. https:\/\/doi.org\/10.1016\/s0140-6736(16)00278-6","journal-title":"Lancet"},{"key":"6716_CR2","doi-asserted-by":"publisher","first-page":"756","DOI":"10.5603\/ep.a2022.0040","volume":"73","author":"M Nowak","year":"2022","unstructured":"Nowak M, Marek B, Kos-Kud\u0142a B et al (2022) Optimization of the treatment of moderate to severe and active thyroid orbitopathy considering the recommendations of the European Group on Graves\u2019 Orbitopathy (EUGOGO) [Optymalizacja leczenia umiarkowanej do ci\u0119\u017ckiej i aktywnej orbitopatii tarczycowej z uwzgl\u0119dnieniem zalece\u0144 European Group on Graves\u2019 Orbitopathy (EUGOGO)]. Endokrynol Pol 73:756\u2013777. https:\/\/doi.org\/10.5603\/ep.a2022.0040","journal-title":"Endokrynol Pol"},{"key":"6716_CR3","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1530\/eje.0.1500605","volume":"150","author":"M Prummel","year":"2004","unstructured":"Prummel M, Strieder T, Wiersinga W (2004) The environment and autoimmune thyroid diseases. Eur J Endocrinol 150:605\u2013618. https:\/\/doi.org\/10.1530\/eje.0.1500605","journal-title":"Eur J Endocrinol"},{"key":"6716_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cellimm.2018.10.005","volume":"339","author":"E Marietta","year":"2019","unstructured":"Marietta E, Horwath I, Balakrishnan B, Taneja V (2019) Role of the intestinal microbiome in autoimmune diseases and its use in treatments. Cell Immunol 339:50\u201358. https:\/\/doi.org\/10.1016\/j.cellimm.2018.10.005","journal-title":"Cell Immunol"},{"key":"6716_CR5","doi-asserted-by":"publisher","unstructured":"Shaheen WA, Quraishi MN, Iqbal TH (2022) Gut microbiome and autoimmune disorders. Clin Exp Immunol 209:uxac057. https:\/\/doi.org\/10.1093\/cei\/uxac057","DOI":"10.1093\/cei\/uxac057"},{"key":"6716_CR6","doi-asserted-by":"publisher","first-page":"13450","DOI":"10.3390\/ijms232113450","volume":"23","author":"N Sawicka-Gutaj","year":"2022","unstructured":"Sawicka-Gutaj N, Gruszczy\u0144ski D, Zawalna N et al (2022) Microbiota alterations in patients with autoimmune thyroid diseases: a systematic review. Int J Mol Sci 23:13450. https:\/\/doi.org\/10.3390\/ijms232113450","journal-title":"Int J Mol Sci"},{"key":"6716_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13073-020-00782-x","volume":"12","author":"DJ Schwartz","year":"2020","unstructured":"Schwartz DJ, Langdon AE, Dantas G (2020) Understanding the impact of antibiotic perturbation on the human microbiome. Genome Med 12:82. https:\/\/doi.org\/10.1186\/s13073-020-00782-x","journal-title":"Genome Med"},{"key":"6716_CR8","doi-asserted-by":"publisher","first-page":"101506","DOI":"10.1016\/j.beem.2021.101506","volume":"35","author":"C Virili","year":"2021","unstructured":"Virili C, Stramazzo I, Centanni M (2021) Gut microbiome and thyroid autoimmunity. Best Pract Res Cl En 35:101506. https:\/\/doi.org\/10.1016\/j.beem.2021.101506","journal-title":"Best Pract Res Cl En"},{"key":"6716_CR9","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1210\/clinem\/dgad030","volume":"108","author":"F Biscarini","year":"2023","unstructured":"Biscarini F, Masetti G, Muller I et al (2023) Gut microbiome associated with graves disease and graves orbitopathy: the INDIGO multicenter european study. J Clin Endocrinol Metab 108:2065\u20132077. https:\/\/doi.org\/10.1210\/clinem\/dgad030","journal-title":"J Clin Endocrinol Metab"},{"key":"6716_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s40618-020-01298-2","volume":"44","author":"T-T Shi","year":"2021","unstructured":"Shi T-T, Xin Z, Hua L et al (2021) Comparative assessment of gut microbial composition and function in patients with Graves\u2019 disease and Graves\u2019 orbitopathy. J Endocrinol Invest 44:297\u2013310. https:\/\/doi.org\/10.1007\/s40618-020-01298-2","journal-title":"J Endocrinol Invest"},{"key":"6716_CR11","doi-asserted-by":"publisher","first-page":"8379","DOI":"10.1038\/s41598-019-44674-6","volume":"9","author":"JD Corr\u00eaa","year":"2019","unstructured":"Corr\u00eaa JD, Fernandes GR, Calderaro DC et al (2019) Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients. Sci Rep-uk 9:8379. https:\/\/doi.org\/10.1038\/s41598-019-44674-6","journal-title":"Sci Rep-uk"},{"key":"6716_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/cei.13158","volume":"195","author":"FD Luca","year":"2019","unstructured":"Luca FD, Shoenfeld Y (2019) The microbiome in autoimmune diseases. Clin Exp Immunol 195:74\u201385. https:\/\/doi.org\/10.1111\/cei.13158","journal-title":"Clin Exp Immunol"},{"key":"6716_CR13","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1530\/eje-21-0479","volume":"185","author":"L Bartalena","year":"2021","unstructured":"Bartalena L, Kahaly GJ, Baldeschi L et al (2021) The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy. Eur J Endocrinol 185:G43\u2013G67. https:\/\/doi.org\/10.1530\/eje-21-0479","journal-title":"Eur J Endocrinol"},{"key":"6716_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12967-019-1971-7","volume":"17","author":"C Huang","year":"2019","unstructured":"Huang C, Shi G (2019) Smoking and microbiome in oral, airway, gut and some systemic diseases. J Transl Med 17:225. https:\/\/doi.org\/10.1186\/s12967-019-1971-7","journal-title":"J Transl Med"},{"key":"6716_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jdsr.2019.03.002","volume":"55","author":"T Hanioka","year":"2019","unstructured":"Hanioka T, Morita M, Yamamoto T et al (2019) Smoking and periodontal microorganisms. Jpn Dent Sci Rev 55:88\u201394. https:\/\/doi.org\/10.1016\/j.jdsr.2019.03.002","journal-title":"Jpn Dent Sci Rev"},{"key":"6716_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000443828","volume":"5","author":"L Bartalena","year":"2016","unstructured":"Bartalena L, Baldeschi L, Boboridis K et al (2016) The 2016 European thyroid association\/European group on graves\u2019 orbitopathy guidelines for the management of Graves\u2019 orbitopathy. European Thyroid J 5:9\u201326. https:\/\/doi.org\/10.1159\/000443828","journal-title":"European Thyroid J"},{"key":"6716_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1530\/eje.1.02230","volume":"155","author":"WM Wiersinga","year":"2006","unstructured":"(EUGOGO) EG on GO, Wiersinga WM, Perros P et al (2006) Clinical assessment of patients with Graves\u2019 orbitopathy: the European group on graves\u2019 orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol 155:387\u2013389. https:\/\/doi.org\/10.1530\/eje.1.02230","journal-title":"Eur J Endocrinol"},{"key":"6716_CR18","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/biomedicines11041012","volume":"11","author":"MG Erdem","year":"2023","unstructured":"Erdem MG, Unlu O, Ates F et al (2023) Oral microbiota signatures in the pathogenesis of euthyroid hashimoto\u2019s thyroiditis. Biomed 11:1012. https:\/\/doi.org\/10.3390\/biomedicines11041012","journal-title":"Biomed"},{"key":"6716_CR19","doi-asserted-by":"publisher","unstructured":"Dong T, Xu S, Chen Z-Y, et al (2023) Prevotella intermedia aggravates subclinical hypothyroidism. J Dent Res 002203452311680. https:\/\/doi.org\/10.1177\/00220345231168052","DOI":"10.1177\/00220345231168052"},{"key":"6716_CR20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cden.2016.11.005","volume":"61","author":"JD Harvey","year":"2017","unstructured":"Harvey JD (2017) Periodontal microbiology. Dent Clin N Am 61:253\u2013269. https:\/\/doi.org\/10.1016\/j.cden.2016.11.005","journal-title":"Dent Clin N Am"},{"key":"6716_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1210\/jc.2006-1824","volume":"92","author":"TJ Cawood","year":"2007","unstructured":"Cawood TJ, Moriarty P, O\u2019Farrelly C, O\u2019Shea D (2007) Smoking and thyroid-associated ophthalmopathy: a novel explanation of the biological link. J Clin Endocrinol Metabolism 92:59\u201364. https:\/\/doi.org\/10.1210\/jc.2006-1824","journal-title":"J Clin Endocrinol Metabolism"},{"key":"6716_CR22","doi-asserted-by":"publisher","first-page":"9473","DOI":"10.1111\/jcmm.16901","volume":"25","author":"M Osman","year":"2021","unstructured":"Osman M, Papon N (2021) Smoking-aggravated oral candidiasis: Nrf2 pathway dampens NLRP3 inflammasome. J Cell Mol Med 25:9473\u20139475. https:\/\/doi.org\/10.1111\/jcmm.16901","journal-title":"J Cell Mol Med"},{"key":"6716_CR23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1600-051x.2006.00934.x","volume":"33","author":"B Baharin","year":"2006","unstructured":"Baharin B, Palmer RM, Coward P, Wilson RF (2006) Investigation of periodontal destruction patterns in smokers and non-smokers. J Clin Periodontol 33:485\u2013490. https:\/\/doi.org\/10.1111\/j.1600-051x.2006.00934.x","journal-title":"J Clin Periodontol"},{"key":"6716_CR24","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.mib.2017.10.030","volume":"40","author":"JR Naglik","year":"2017","unstructured":"Naglik JR, K\u00f6nig A, Hube B, Gaffen SL (2017) Candida albicans\u2013epithelial interactions and induction of mucosal innate immunity. Curr Opin Microbiol 40:104\u2013112. https:\/\/doi.org\/10.1016\/j.mib.2017.10.030","journal-title":"Curr Opin Microbiol"},{"key":"6716_CR25","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1902\/jop.2015.150088","volume":"86","author":"MJ Smit","year":"2015","unstructured":"Smit MJ, Westra J, Brouwer E et al (2015) Commentary: periodontitis and rheumatoid arthritis: what do we know? J Periodontol 86:1013\u20131019. https:\/\/doi.org\/10.1902\/jop.2015.150088","journal-title":"J Periodontol"},{"key":"6716_CR26","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1600-051x.2012.01885.x","volume":"39","author":"W Nesse","year":"2012","unstructured":"Nesse W, Westra J, Wal JE et al (2012) The periodontium of periodontitis patients contains citrullinated proteins which may play a role in ACPA (anti-citrullinated protein antibody) formation. J Clin Periodontol 39:599\u2013607. https:\/\/doi.org\/10.1111\/j.1600-051x.2012.01885.x","journal-title":"J Clin Periodontol"},{"key":"6716_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.17219\/dmp\/131266","volume":"58","author":"V Nguyen","year":"2021","unstructured":"Nguyen V, Nguyen T, Huynh N et al (2021) Effects of non-surgical periodontal treatment in rheumatoid arthritis patients: a randomized clinical trial. Dent Medical Problems 58:97\u2013105. https:\/\/doi.org\/10.17219\/dmp\/131266","journal-title":"Dent Medical Problems"},{"key":"6716_CR28","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1007\/s10266-020-00566-0","volume":"109","author":"MF Moura","year":"2021","unstructured":"Moura MF, Cota LOM, Silva TA et al (2021) Clinical and microbiological effects of non-surgical periodontal treatment in individuals with rheumatoid arthritis: a controlled clinical trial. Odontology 109:484\u2013493. https:\/\/doi.org\/10.1007\/s10266-020-00566-0","journal-title":"Odontology"},{"key":"6716_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40168-017-0252-z","volume":"5","author":"JD Corr\u00eaa","year":"2017","unstructured":"Corr\u00eaa JD, Calderaro DC, Ferreira GA et al (2017) Subgingival microbiota dysbiosis in systemic lupus erythematosus: association with periodontal status. Microbiome 5:34. https:\/\/doi.org\/10.1186\/s40168-017-0252-z","journal-title":"Microbiome"},{"key":"6716_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2014.02.004","volume":"152","author":"A Szymula","year":"2014","unstructured":"Szymula A, Rosenthal J, Szczerba BM et al (2014) T cell epitope mimicry between Sj\u00f6gren\u2019s syndrome Antigen A (SSA)\/Ro60 and oral, gut, skin and vaginal bacteria. Clin Immunol 152:1\u20139. https:\/\/doi.org\/10.1016\/j.clim.2014.02.004","journal-title":"Clin Immunol"},{"key":"6716_CR31","doi-asserted-by":"publisher","first-page":"927520","DOI":"10.3389\/fdata.2022.927520","volume":"5","author":"L Gao","year":"2022","unstructured":"Gao L, Cheng Z, Zhu F et al (2022) The oral microbiome and its role in systemic autoimmune diseases: a systematic review of big data analysis. Frontiers Big Data 5:927520. https:\/\/doi.org\/10.3389\/fdata.2022.927520","journal-title":"Frontiers Big Data"},{"key":"6716_CR32","doi-asserted-by":"publisher","first-page":"7538","DOI":"10.3390\/ijms21207538","volume":"21","author":"P Pignatelli","year":"2020","unstructured":"Pignatelli P, Fabietti G, Ricci A et al (2020) How periodontal disease and presence of nitric oxide reducing oral bacteria can affect blood pressure. Int J Mol Sci 21:7538. https:\/\/doi.org\/10.3390\/ijms21207538","journal-title":"Int J Mol Sci"},{"key":"6716_CR33","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1186\/s12967-022-03785-x","volume":"20","author":"KA Maki","year":"2022","unstructured":"Maki KA, Ganesan SM, Meeks B et al (2022) The role of the oral microbiome in smoking-related cardiovascular risk: a review of the literature exploring mechanisms and pathways. J Transl Med 20:584. https:\/\/doi.org\/10.1186\/s12967-022-03785-x","journal-title":"J Transl Med"},{"key":"6716_CR34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/prd.12379","volume":"87","author":"FQ Pirih","year":"2021","unstructured":"Pirih FQ, Monajemzadeh S, Singh N et al (2021) Association between metabolic syndrome and periodontitis: The role of lipids, inflammatory cytokines, altered host response, and the microbiome. Periodontol 2000 87:50\u201375. https:\/\/doi.org\/10.1111\/prd.12379","journal-title":"Periodontol 2000"},{"key":"6716_CR35","doi-asserted-by":"publisher","first-page":"11521","DOI":"10.3390\/ijerph182111521","volume":"18","author":"K Nijakowski","year":"2021","unstructured":"Nijakowski K, Gruszczy\u0144ski D, Surdacka A (2021) Oral health status in patients with inflammatory bowel diseases: a systematic review. Int J Environ Res Public Heal 18:11521. https:\/\/doi.org\/10.3390\/ijerph182111521","journal-title":"Int J Environ Res Public Heal"},{"key":"6716_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12020-014-0496-3","volume":"49","author":"MG Kudiyirickal","year":"2015","unstructured":"Kudiyirickal MG, Pappachan JM (2015) Diabetes mellitus and oral health. Endocrine 49:27\u201334. https:\/\/doi.org\/10.1007\/s12020-014-0496-3","journal-title":"Endocrine"},{"key":"6716_CR37","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s40618-022-01902-7","volume":"46","author":"Y Li","year":"2023","unstructured":"Li Y, Luo B, Tong B et al (2023) The role and molecular mechanism of gut microbiota in Graves\u2019 orbitopathy. J Endocrinol Invest 46:305\u2013317. https:\/\/doi.org\/10.1007\/s40618-022-01902-7","journal-title":"J Endocrinol Invest"},{"key":"6716_CR38","doi-asserted-by":"publisher","first-page":"173","DOI":"10.33073\/pjm-2022-016","volume":"71","author":"H Zhao","year":"2022","unstructured":"Zhao H, Yuan L, Zhu D et al (2022) Alterations and mechanism of gut microbiota in graves\u2019 disease and hashimoto\u2019s thyroiditis. Pol J Microbiol 71:173\u2013189","journal-title":"Pol J Microbiol"},{"key":"6716_CR39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s40168-018-0478-4","volume":"6","author":"G Masetti","year":"2018","unstructured":"Masetti G, Moshkelgosha S, K\u00f6hling H-L et al (2018) Gut microbiota in experimental murine model of Graves\u2019 orbitopathy established in different environments may modulate clinical presentation of disease. Microbiome 6:97. https:\/\/doi.org\/10.1186\/s40168-018-0478-4","journal-title":"Microbiome"},{"key":"6716_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/odi.13271","volume":"27","author":"M Benli","year":"2021","unstructured":"Benli M, Batool F, Stutz C et al (2021) Orofacial manifestations and dental management of systemic lupus erythematosus: a review. Oral Dis 27:151\u2013167. https:\/\/doi.org\/10.1111\/odi.13271","journal-title":"Oral Dis"},{"key":"6716_CR41","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1308\/204268513x13776914744952","volume":"4","author":"N Kumar","year":"2013","unstructured":"Kumar N, Brooke A, Burke M et al (2013) The oral management of oncology patients requiring radiotherapy, chemotherapy and\/or bone marrow transplantation. Fac Dent J 4:200\u2013203. https:\/\/doi.org\/10.1308\/204268513x13776914744952","journal-title":"Fac Dent J"},{"key":"6716_CR42","doi-asserted-by":"publisher","first-page":"689","DOI":"10.14219\/jada.archive.1999.0279","volume":"130","author":"N Treister","year":"1999","unstructured":"Treister N, Glick M (1999) Rheumatoid arthritis: a review and suggested dental care considerations. J Am Dent Assoc 130:689\u2013698. https:\/\/doi.org\/10.14219\/jada.archive.1999.0279","journal-title":"J Am Dent Assoc"},{"key":"6716_CR43","doi-asserted-by":"publisher","first-page":"e13437","DOI":"10.1111\/eci.13437","volume":"51","author":"E Descamps","year":"2021","unstructured":"Descamps E, Gorlier C, Ottaviani S et al (2021) Screening of dental and sinus infections in rheumatoid arthritis. Eur J Clin Investig 51:e13437. https:\/\/doi.org\/10.1111\/eci.13437","journal-title":"Eur J Clin Investig"},{"key":"6716_CR44","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41577-020-00488-6","volume":"21","author":"G Hajishengallis","year":"2021","unstructured":"Hajishengallis G, Chavakis T (2021) Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol 21:426\u2013440. https:\/\/doi.org\/10.1038\/s41577-020-00488-6","journal-title":"Nat Rev Immunol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06716-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-024-06716-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06716-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T09:51:30Z","timestamp":1749462690000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-024-06716-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["6716"],"URL":"https:\/\/doi.org\/10.1007\/s00417-024-06716-2","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,3]]},"assertion":[{"value":"17 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We adhered to the ethical standards of the Declaration of Helsinki when we collected, analyzed and reported the data. Due to the retrospective design, the bioethics committee approval is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}